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Metabolomic analysis of human vitreous humor differentiates
ocular inflammatory disease
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Robert A.H. Scott,2 Philip I. Murray,2 Graham R. Wallace2
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Purpose: Vitreoretinal disorders lack specific biomarkers that define either disease type or response to treatment. We
have used NMR-based metabolomic analysis of human vitreous humor to assess the applicability of this approach to the
study of ocular disease.
Methods: Vitreous samples from patients with a range of vitreoretinal disorders were subjected to high-resolution 1H-
nuclear magnetic resonance spectroscopy (NMR). Good quality spectra were derived from the vitreous samples, and the
profiles were analyzed by three different methods.
Results: Principal component analysis (PCA) showed a wide dispersal of the different clinical conditions. Partial least
squares discriminant analysis (PLS-DA) was used to define differences between lens-induced uveitis (LIU) and chronic
uveitis (CU) and could distinguish between these conditions with a sensitivity of 78% and specificity of 85%. A genetic
algorithm coupled with multivariate classification identified a small number of spectral components that showed clear
discrimination between LIU and CU samples with sensitivity and specificity >90%. Assignment of specific resonances
indicated that some metabolites involved in the arginase pathway were significantly more abundant in LIU than CU.
Conclusion: The discrimination we observed based on PCA, PLS-DA, and multivariate variable selection analysis of the
NMR spectra suggests that a complex mix of metabolites are present in vitreous fluid of different uveitic conditions as a
result of the disease process. Collectively the data demonstrates the efficacy of metabolomic analysis to distinguish
between ocular inflammatory diseases.
Vitreoretinal disorders encompass a complex group of
diseases with different pathogenetic mechanisms including
inflammatory and proliferative conditions. Many of these,
such as uveitis, lack specific biomarkers that define either
disease type or response to treatment. A range of possible
endpoints is used to define outcome, but it is not clear how
these relate to each other in different patients or studies [1].
This is particularly relevant for clinical trials when comparing
a novel treatment to established therapy. Several studies have
identified inflammatory mediators, such as cytokines,
chemokines, and growth factors or single nucleotide
polymorphisms with disease type, activity, and response to
treatment, yet there is no clear result that can relate to clinical
response [2-6]. This, in part, results from the narrowly focused
analysis of particular candidate molecules or single nucleotide
polymorphisms (SNP), selection of which is based on
knowledge of disease type and the immune response. More
recently, multiplex protein and gene analysis have been
utilized in ocular disease and results have shown profiles of
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interest, although in the case of proteins, still within a selected
group of molecules [7-9].
An even broader global profiling of the network of
proteins or metabolites found in cells, tissues or fluids can
increase our understanding of the multiple interacting
processes involved in complex systems. One such approach
is metabolomics, which analyses the metabolic consequences
of gene expression and protein activity [10]. Metabolomics
most often combines either high-field nuclear magnetic
resonance or mass spectrometry of biofluids with pattern
recognition (principal components analysis) within the
resulting dataset. It is based on the concept that metabolic
properties of tissues predispose to or are altered by disease
processes, and these changes can be reflected in characteristic
patterns (metabolomic profile) in blood, urine, or other body
fluids.
Metabolomics has been applied to the study of coronary
heart disease, where analysis of serum nuclear magnetic
resonance (NMR) spectra appeared to distinguish between
different degrees of coronary artery stenosis. The features in
the NMR spectra contributing to this discrimination were
largely lipid components and yet classical biochemical
analysis of the usual lipid profiles was unable to discriminate
between these patients [11]. Recently, metabolomic analysis
has  been  reported  to  discriminate  in   the  prognosis   and
diagnosis of other human diseases, including diabetes, blood
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pressure, and cancer [12-14]. In a study of prostate cancer a
novel metabolic marker of potential prognostic importance
was recently identified which was derived from a pathway not
previously associated with this disease [15]. Thus it seems that
the multiplexed analysis inherent in this approach, which
takes into account all metabolite signals regardless of whether
they have been specifically identified, is able to provide
information not available by other means.
The analysis of eye disease using such approaches has
been reported, but this has been limited to investigations of
animal models. For example, significant changes in a number
of metabolites in rabbit eye aqueous humor [16] and in rat lens
[17] has been seen following UV-B exposure, and a rise in
lactate in vitreous humor has been observed in a rabbit model
of ocular hypertension [18]. High resolution analysis of
human eye disease has not been reported but an analysis using
in vivo NMR spectroscopy has identified lactate as a dominant
metabolite in human vitreous [19] suggesting that high
resolution metabolomic studies might reveal novel
biomarkers in human ocular disease.
In this study we have analyzed metabolite fingerprints in
vitreous humor from patients with various vitreoretinal
conditions, using high-resolution 1H-nuclear magnetic
resonance spectroscopy in conjunction with principal
component analysis (PCA), partial least squares discriminant
analysis (PLS-DA), and multivariate variable selection
(MVS) for classification to determine if metabolic profiles
could define disease states.
METHODS
Patients: Patients were recruited from the tertiary referral
Vitreoretinal Unit of the Birmingham and Midland Eye
Centre. A total of 42 vitreous humor samples were obtained
from patients undergoing pars plana vitrectomy for various
vitreoretinal disorders: chronic non-infectious uveitis (CU;
n=20), lens-induced uveitis LIU (n=9); proliferative diabetic
retinopathy (PDR, n=2), proliferative vitreoretinopathy
(PVR, n=2), rhegmatogenous retinal detachment (n=7),
Candida endophthalmitis (n=1), and Varicella Zoster virus
acute retinal necrosis (ARN, n=1). The CU patients comprised
sixteen patients with panuveitis (two with sarcoidosis), two
with intermediate uveitis (pars planitis), and two with Fuchs’
heterochromic cyclitis (FHC). All of the eyes in the CU group
had chronic relapsing and remitting disease and were operated
on at a time of remission. None had ‘burnt-out disease’, The
indications for vitrectomy in the panuveitis and intermediate
uveitis patients were vitreous opacities and cystoid macular
edema with epiretinal membrane formation/vitreo-macular
traction. None of these patients had any anterior chamber
activity with the exception of FHC patients who had mild (+1)
inflammation of the AC. Of these patients, all apart from 3
were receiving systemic immunosuppression. The indication
for vitrectomy in the FHC patients was vitreous opacities, and
none of these patients were on any topical or systemic
corticosteroid therapy. The LIU group comprised patients that
within the previous 14 days had undergone complicated
phacoemulsification cataract surgery where the lens nucleus
had inadvertently dropped into the vitreous cavity, resulting
in an acute form of uveitis. All patients in the LIU group had
active uveitis and were receiving topical corticosteroid, and
none were on systemic anti-inflammatory or
immunosuppressive therapy at the time of vitrectomy. Local
Research Ethics approval and patient consent was obtained in
all cases.
Metabolomic analysis: An undiluted vitreous sample was
taken at the beginning of surgery and was centrifuged at 300
rpm for 10 min and stored at –80 °C until analysis. After
thawing, samples (0.1 or 0.2 ml) were centrifuged at high-
speed (13,000x g), diluted 2:1 with D2O/H2O containing NaCl
(150 mM), trimethylsilyl 2,2,3,3-tetradeuteropropionic acid
(TMSP), and sodium phosphate (20 mM) pH 7.4. One-
dimensional 1H spectra were acquired at 298 °K using a
standard spin-echo pulse sequence with water suppression
using excitation sculpting on a Bruker DRX 500MHz NMR
spectrometer equipped with a cryoprobe. Chemical shifts
were calibrated with respect to the chemical shift position of
the TMSP resonance. Spectra were segmented into 0.005 ppm
(2.5 Hz) chemical shift ‘bins’ between 0.2 and 10.0 ppm using
ProMetab version 2 and the spectral area within each bin was
integrated [20]. Bins between 4.5 and 5.0 ppm containing
residual water were removed.
The total spectral area of the remaining bins was
normalized and the binned data describing each spectrum
were then compiled into a matrix, with each row representing
an individual sample. Finally, the columns were mean-
centered before multivariate analysis.
Statistical analyses: Principal components analysis (PCA) of
the pre-processed spectra was conducted using PLS_Toolbox
(Version 4.1; Eigenvector Research, Manson, WA) within
MATLAB (version 7.5; The MathWorks, Cambridge, UK).
PCA reduces the dimensionality of data and summarizes the
similarities and differences between multiple NMR spectra
using scores plots. This requires calculation of new variables
(the PCs) that are weighted linear combinations of the original
chemical shift bins (presented as loads plots).
Partial least square discriminant analysis (PLS-DA) was
then employed using PLS_Toolbox. This validated [21,22]
supervised analysis technique was used to build a training
model to evaluate separation between groups based on known
clinical diagnosis. The PLS-DA model was cross-validated
using Venetian blinds [21,22], a method which re-assigns
randomly selected blocks of data to the PLS-DA model to
determine the accuracy of the model in correctly assigning
class membership.
Multivariate variable selection (MVS) for classification
was performed using the GALGO package [23] on the pre-
processed spectra. GALGO combines genetic algorithm
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driven multidimensional searches and statistical classification
methods to find combinations of variables that can distinguish
between sample classes. Our analysis identified 800
predictive gene subsets using GAs coupled to a k-nearest-
neighbor classification method. These models were pooled
and the 50 topmost frequent peaks were selected to design a
single representative statistical model using a forward
selection strategy. The best classification model was then
chosen.
Provisional assignment of the major peaks in the spectra
was done using Chenomx NMR Suite version 4 (Chenomx,
Edmonton, Alberta, Canada) which is an NMR spectral
analysis program for metabolic profiling, which provides
library over 230 compounds which may be present in biofluid
samples, in conjunction with the human metabolite database
[24] and published literature [11,25]. Comparison of peak
heights of selected metabolites was made using an unpaired
Student T test.
RESULTS
NMR spectroscopy is a relatively insensitive method usually
requiring samples to contain concentrations of target
molecules in the high micromolar range. Our first concern was
whether useful NMR spectra could be derived from the small
vitreous humor samples available using a highly sensitive
NMR instrument equipped with a cyroprobe that is able to
minimize electronic noise in the system and thus maximize its
sensitivity to the small NMR signals from dilute samples.
Even with the small volumes available it was possible to
acquire well-resolved spectra (Figure 1A). Acquisition time
for each spectrum was relatively short, of the order of 10 min,
making it possible to process a set of samples in a reasonable
time. Although we used an NMR pulse sequence aimed at
minimizing the detrimental effects of proteins present in the
samples, which tend to produce amorphous humps within the
spectra, this seemed to be less of a problem with the vitreous
samples than with serum. The concentration of proteins in
vitreous is considerably less than that in serum and this made
a contribution to the quality of the spectra derived from these
small volumes.
The NMR spectra are data rich entities but to make
comparison and analysis possible some simplification is
necessary. The first step is “binning” of the data to turn each
spectrum from a continuous analogue signal into an array of
data points. Each spectrum is segmented into approximately
2,000 regions and the area under each segment integrated.
Since the concentration of individual samples can vary
considerably it is necessary to normalize the total spectral area
of each sample and the binned data describing each spectrum
were then compiled into a matrix, with each row representing
an individual sample. The spectra contained three dominant
resonances (Figure 1A, inset) although many less-intense
peaks in the spectrum were also well resolved (Figure 1A). To
equalize the weightings of the smaller and larger peaks in the
subsequent analysis every element was log-transformed
(Figure 1B).
Principal Components Analysis (PCA) was then applied
to the transformed datasets. With NMR data, PCA assesses
the covariance around the mean of the data in each “bin” or
region of the spectrum and assesses how these relate to each
other. The principal components (PCs) extracted from the data
describe the direction of the greatest variation in the data, and
often a relatively small number of PCs (2 or 3) are able to
describe the major covariance trends within the data. PCA
analysis of the NMR spectra from 42 samples of vitreous fluid
indicated that two principal components could account for
over 75% of the covariance and these two PCs are plotted
against each other (Figure 2A). Different disease groups
Figure 1. A typical 1D 1H NMR spectrum of vitreous eye fluid from
a uveitis patient. A: The original spectrum labeled to show the
regions in which some typical biofluid components are known to give
rise to resonances. The spectrum has been scaled to highlight the
detail; the inset is the unscaled whole spectrum. B: A data reduced
spectrum in which the region between 4.5 and 5 ppm has been deleted
so that any contribution from residual water signal is eliminated. This
spectrum has been “binned” into 0.005 Hz regions.
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showed a distinct separation on the plot of PC1 against PC2.
Samples were distributed widely across the PC2 axis with no
particular trends apparent. There is however discrimination
based on the value of PC1, for example both PVR samples
had positive PC1 values while both PDR samples had negative
values. Similarly the patients with LIU were clustered with
samples from patients with rhegmatogenous retinal
detachment.
This discrimination was more apparent with the two
largest groups of samples, LIU and CU. When these samples
were assessed on their own, LIU samples were confined to the
left side of the PC1 plot, suggesting a negative contribution
of PC1 in these spectra while patients with CU were mainly
Figure 2. Principal components analysis of NMR spectra of vitreous
fluid from uveitis patients. The processed and binned spectra were
subjected to PCA analysis and the two major PC which accounted
for 79.9% of the variance have been plotted. A: Shows all the samples
from a broad range of uveitic conditions that were assessed: Chronic
uveitis (●), Non-inflammatory – retinal detachment (◆), PVR (▲),
PDR (□), ARN (◆), Candida (◆), ERM (■) and Lens-induced uveitis
(○). B: Vitreous from chronic uveitis and lens-induced uveitis
patients Chronic uveitis (●), Lens-induced uveitis (○). This subset of
patients was plotted since the PCA discriminated well with these
conditions.
confined to the right, suggesting a positive contribution of
PC1 (Figure 2B).
The supervised clustering analysis Partial Least Squares
Discriminant Analysis (PLS-DA) was carried out to enhance
the separation seen with the PCA. The PLS-DA model was
cross-validated using Venetian blinds [21,22], a method
which re-assigns randomly selected blocks of data to the PLS-
DA model to determine the accuracy of the model in correctly
assigning class membership. Using this approach an improved
separation was seen between LIU and CU in the plot of Latent
Variables (Figure 3A). PLS-DA allows a predictive model to
be generated and this was able to accurately predict which
class a sample came from (Figure 3B) with a sensitivity of
78% and specificity of 85%.
To improve the classification further, a Genetic
Algorithm (GA) approach was applied to remove variables
Figure 3. Partial least squares discriminant analysis (PLS-DA) of
vitreous fluid NMR spectra from lens-induced uveitis and chronic
uveitis patients. A PLS-DA model was constructed to predict
diagnostic groups. A: Latent variable plot of the PLS-DA model,
showing improved discrimination between LIU and chronic uveitis
compared with the PCA analysis (Figure 2). B: Prediction of the
group membership from the PLSDA. The model was cross validated,
and was able to predict the classes, LIU and chronic uveitis, with
sensitivity of 78% and specificity of 85%.
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that were not related to class differences. After GA several
models were produced and in the best of these, the number of
variables (NMR bins) was reduced to 13 that give a high
discrimination power to classify the samples from patients
with LIU and CU. The results showed that a selection of 13
bins from the spectra gave the maximum separation between
the two sets of samples (Figure 4A), and the loadings of each
bin used to define the different samples (Figure 4B). This
model was confirmed by cluster analysis and Figure 4C shows
a heat map displaying the relative contribution of each of these
regions of the spectra which shows that the discrimination was
dominated by a limited number of spectral regions, although
many other areas across the spectra contribute to the power of
the discrimination. This model was then used to classify each
sample and all LIU samples were assigned to the correct
predictive class (Figure 4D). Similarly, 18/20 of the CU
samples were assigned to a unique group. The other two
samples, although assigned to the CU group, were split
between class I (CU) and class II (LIU) and these were the
two samples from patients with FHC. The sensitivity and
specificity for GALGO analysis was >90% (Figure 4D).
All three analytical approaches indicated that the
metabolic profile were sufficiently unique in LIU and CU to
give a clear discrimination between these two groups. By
plotting the contribution of each “bin” of the spectra to the
covariance in the PLS-DA analysis it is possible to gain
insights into categories of metabolites that may contribute to
the apparent discrimination between samples. Such loadings
for LV1 and LV2 for the data from LIU and CU in Figure 3,
can be plotted. It can be seen that the regions of the spectrum
at 5.8 ppm and from 3 to 4 ppm make a negative contribution
to LV1 as do a number of peaks between 1 and 3 ppm, while
other regions make a positive contribution. The situation is
different with the LV2 plot with three prominent peaks
apparent, but since LV2 does not segregate the diseases
(Figure 3) it suggests these peaks do not contribute to the
differences observed. (Figure 5A,B)
Based on these loadings plots we tentatively identified a
number of metabolites represented in the spectra. Direct
comparison of the peak heights of a number of these showed
some significant differences between LIU and CU. There was
a significant increase in oxaloacetate (p=0.0006), glucose
(p=0.026), and urea (p=0.0003) in LIU samples compared to
CU. By comparison lactate, acetate and citrate peaks showed
no difference between the samples (Figure 5C).
DISCUSSION
This study shows for the first time that metabolomic analysis
of vitreous humor samples can define different types of
vitreoretinal disease. Specifically, two forms of uveitis, LIU
and CU, could be segregated, with samples from patients with
another form of chronic uveitis FHC showing a similar
analysis to LIU samples. Moreover the FHC samples could be
separated from LIU samples by classification analysis. In
Figure 4. Multivariate variable selection
of NMR spectra of vitreous from lens-
induced uveitis and chronic uveitis
patients. A: PCA analysis of LIU versus
chronic uveitis following GA selection
of NMR spectral bins which best
discriminated between the conditions.
833 solutions were found in 2,199
search cycles matched with the
corresponding spectra. B: Forward
selection procedure using the 15 most
frequent bins. The overall accuracy is
shown in the vertical axis and the ranked
bins in the horizontal axis. C: The best
model containing the 15 most frequent
bins generated by the forward selection
procedure. Bins are drawn in the vertical
axis whereas samples in the horizontal
axis. Color means bin intensity.
Hierarchical clustering from bins is
shown for illustrative purposes. D:
Prediction of class (disease)
membership based on the best model.
All samples were allocatable to one of
the two classes and prediction of class
membership could be made with
sensitivity and specificity of over 90%.
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proliferative disease, proliferative vitreoretinopathy (PVR)
and proliferative diabetic retinopathy (PDR), samples could
be separated, while non-inflammatory retinal detachment
samples clustered together. Finally, individual peaks could be
identified and differences in such metabolites shown to be
significantly different in the LIU and CU vitreous samples.
This data, though preliminary, shows that metabolomics could
potentially be useful in the diagnosis of, and identification of
biomarkers in vitreoretinal disease. There are potential
sources of bias in this study that relate to the patient
population. Patients with CU, with the exception of
individuals with FHC were on systemic treatment for their
conditions, while LIU patients received topical steroids.
However, although the extent of inflammation may differ
between the groups, it only forms part of the metabolic profile
and treatment alone does not directly influence the
metabolites. Secondly, it is not possible to obtain longitudinal
samples to clearly address the effect of treatment, however,
current studies on serum and urine samples will clarify this
issue.
Regardless of such caveats, the separation of LIU and
FHC from CU samples is particularly interesting. LIU could
be termed phacoantigenic and is an acute granulomatous
reaction that probably represents an antigenic reaction against
proteins released from the retained lens fragments after
disruption of the lens capsule [26]. CU samples were
predominantly from patients with idiopathic disease with the
exception of one patient with sarcoidosis. Although there were
only two FHC samples, this condition has a distinct clinical
phenotype from other types of uveitis, and several previous
studies have identified differences between FHC and CU
patients in vitreous cellular infiltrate and cytokine production,
suggesting a Th1 mediated response with CD8+ cells  and  few
B cells as characteristic of FHC [27,28]. Recent studies have
linked  a  positive  antibody  titer  to  rubella virus to FHC,
suggesting a viral etiology supported by the cytotoxic T cell
findings  [29,30].  By  comparison,  idiopathic CU is by
definition long-standing, mediated by T lymphocytes and
inflammatory   cytokines. How these  different etiologies
impact on themetabolome is a current area of interest.
Figure 5. Assessment of the contribution
of regions of the NMR spectra and
specific metabolites to the
discrimination between lens-induced
and chronic uveitis. A: Loadings plots
from the PLSDA analysis which
indicates regions of the spectra which
provide the greatest degree of
discrimination between the two forms of
uveitis. Positive peaks correspond to
metabolites that are at higher
concentration in the chronic relative to
the LIU, and vice versa. B: Based on the
original spectra and the loadings plot,
peak heights of prominent metabolites
resonances were plotted for each
sample. Peak heights were compared
using a T test.
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The presence of lactate in human vitreous humor has been
reported based on observations using in vivo NMR
spectroscopy with a voxel focused largely on the vitreous
region [19]. Variations in vitreous lactate levels following
induced ocular hypertension in the rabbit have also been
reported [18]. We can confirm here that lactate is present as a
major metabolite in human vitreous, suggesting limited
availability of oxygen within the eye. However, we saw no
significant variation in the levels between chronic and lens
induced uveitis, suggesting that the inflammatory processes
were not inducing changes in oxygen demand or delivery. The
significant differences in oxaloacetate and urea we observed
are of interest in these inflammatory conditions as both
molecules are involved in the urea cycle. In particular, urea is
produced in the metabolism of arginine to ornithine, a process
that has been described in both activated macrophages and
endothelium at the expense of nitric oxide production [31]. In
macrophages, alternatively activated cells (M2) produce
ornithine in response to lipopolysaccharide (LPS), and
ornithine stimulates cell proliferation while nitric oxide is
known to inhibit such a response [32,33]. Similarly, ornithine
synthesis has been described in human umbilical vein
endothelial cells (HUVEC) stimulated with cytokines and
LPS, which induce endothelial cell proliferation [34]. That
levels of these molecules were significantly different in
samples from patients with LIU may be due to the nature of
the conditions, LIU presents as an acute response to lens
fragments penetrating the vitreous cavity, while CU is by
definition from patients with longstanding disease.
The cellular infiltrate present in uveitic vitreous suggests
that leukocyte-derived metabolites may contribute to the
profiles seen, since many of the metabolites appear to be
derived from intracellular metabolic pathways. However,
resident cells might produce other metabolites so the
discrimination we have seen may better reflect the total
cellular activity rather than metabolite production from just
infiltrating cells. While we have attempted to assign peaks to
known metabolites, the contribution of the whole spectrum of
molecules may be critical in its usefulness in disease
assessment and the MVS model we built confirms this and
shows that as few as 13 regions of the spectra can be used to
discriminate between samples. The different processes
involved in these conditions that contribute to the metabolic
profiles are supported by analysis of factors in vitreous fluid
which showed growth factors and cytokines specific for each
disease state [35].
In conclusion, this is the first description of metabolomic
analysis of human inflammatory disease, and of vitreous
samples in conjunction with appropriate bioinformatic
analysis. The data shows a clear separation between different
disease types with high sensitivity and specificity. While
prospective validation studies on both metabolic profiles and
metabolite identification are required, such global profiling is
currently being tested with regards to prognosis, diagnosis and
response to treatment in several disease states, and
importantly whether such discrimination can be found in
metabolic profiles from serum samples from these patients.
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